Literature DB >> 9232281

Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury.

H Carsin1, M Assicot, F Feger, O Roy, I Pennacino, H Le Bever, P Ainaud, C Bohuon.   

Abstract

To determine the evolution and significance of circulating procalcitonin (ProCT), IL-6 TNF alpha and endotoxin levels early after thermal injury, we performed a prospective, single unit, longitudinal study. Forty burn patients with total body surface area (TBSA) > 30 per cent were studied, of whom 33 suffered an inhalation injury. Blood samples were taken on the day of admission, every 4 h during the first day and daily during the first week. All patients had increased ProCT and IL-6 levels without any proven infection. Endotoxin and TNF alpha levels remained very low or undetectable. ProCT and IL-levels correlated well with the severity of skin burn injury (respectively, p < 0.006 and p < 0.028, using the non-parametric Kruskal-Wallis test). ProCT levels are not associated with smoke inhalation. ProCT and IL6 are prognostic factors of mortality at the time of admission but less reliable than the clinical UBS (unit burn standard) score. Endotoxin and TNF alpha were undetectable, suggesting that the problem of the early gut bacterial translocation remains to be proven.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232281     DOI: 10.1016/s0305-4179(96)00124-6

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  21 in total

1.  Age-related immune responses after burn and inhalation injury are associated with altered clinical outcomes.

Authors:  John H Frankel; Devin M Boe; Joslyn M Albright; Eileen B O'Halloran; Stewart R Carter; Christopher S Davis; Luis Ramirez; Ellen L Burnham; Richard L Gamelli; Majid Afshar; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2017-10-26       Impact factor: 4.032

2.  Procalcitonin as a Predictive Marker for Bacteremia in Children With a Central Line and Fever.

Authors:  Jennifer Damman; Patricio Arias; John Kerner; Ke-You Zhang; Melody Dehghan; Gomathi Krishnan; Colleen Nespor; Rachel Bensen; K T Park
Journal:  Hosp Pediatr       Date:  2019-06

3.  Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery.

Authors:  Serdar Celebi; Ozge Koner; Ferdi Menda; Huriye Balci; Alican Hatemi; Kubilay Korkut; Figen Esen
Journal:  Intensive Care Med       Date:  2006-04-28       Impact factor: 17.440

4.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

5.  Value of procalcitonin for diagnosing perioperative pneumonia, urinary infections and superficial surgical site infections in patients undergoing primary hip and knee arthroplasty.

Authors:  Lixuan Zhang; Daozhang Cai; Hanming Guo
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

Review 6.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

Review 7.  Clinical Utility and Measurement of Procalcitonin.

Authors:  Intan Samsudin; Samuel D Vasikaran
Journal:  Clin Biochem Rev       Date:  2017-04

8.  A Procalcitonin and C-Reactive Protein-Guided Clinical Pathway for Reducing Antibiotic Use in Children Hospitalized with Bronchiolitis.

Authors:  Elisa Barbieri; Sara Rossin; Carlo Giaquinto; Liviana Da Dalt; Daniele Dona'
Journal:  Children (Basel)       Date:  2021-04-28

9.  Differential expression of the immunoinflammatory response in trauma patients: burn vs. non-burn.

Authors:  James E Mace; Myung S Park; Alejandra G Mora; Kevin K Chung; Wenjun Martini; Christopher E White; John B Holcomb; Gerald A Merrill; Michael A Dubick; Steven E Wolf; Charles E Wade; Martin G Schwacha
Journal:  Burns       Date:  2011-11-21       Impact factor: 2.609

Review 10.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.